Kyung K. Kim

Hwasun, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 66 publications

Targeting KITENIN signaling in cancer progression and therapeutic resistance: mechanistic insights and future directions.

Targeting KITENIN signaling in cancer progression and therapeutic resistance: mechanistic insights and future directions.

Journal: Cancer cell international

Published: November 07, 2025

KITENIN-CCL20 axis is a potential therapeutic target for modulating immunosuppressive tumor microenvironment in glioblastoma.

KITENIN-CCL20 axis is a potential therapeutic target for modulating immunosuppressive tumor microenvironment in glioblastoma.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: August 17, 2025

Brain metastasis-associated cancer fibroblasts drive tumor progression and therapeutic resistance through IL26 and CX3CL1 signaling in non-small-cell lung cancer.

Brain metastasis-associated cancer fibroblasts drive tumor progression and therapeutic resistance through IL26 and CX3CL1 signaling in non-small-cell lung cancer.

Journal: Experimental hematology & oncology

Published: March 12, 2025

Emodin disrupts the KITENIN oncogenic complex by binding ErbB4 and suppresses colorectal cancer progression in dual blockade with KSRP-binding compound.

Emodin disrupts the KITENIN oncogenic complex by binding ErbB4 and suppresses colorectal cancer progression in dual blockade with KSRP-binding compound.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: August 03, 2024

Metastasis-enhancing protein KITENIN confers temozolomide resistance on glioblastoma with unmethylated MGMT via upregulation of cancer stem cell makers.

Metastasis-enhancing protein KITENIN confers temozolomide resistance on glioblastoma with unmethylated MGMT via upregulation of cancer stem cell makers.

Journal: Clinical and translational medicine

Published: July 09, 2024

Chrysophanol inhibits of colorectal cancer cell motility and energy metabolism by targeting the KITENIN/ErbB4 oncogenic complex.

Chrysophanol inhibits of colorectal cancer cell motility and energy metabolism by targeting the KITENIN/ErbB4 oncogenic complex.

Journal: Cancer cell international

Published: January 24, 2024

Atranorin Impedes Glioma Invasiveness and Progression by Inhibiting the Epithelial-Mesenchymal Transition and Stemness in Monotherapy and in Combination Therapy With Temozolomide.

Atranorin Impedes Glioma Invasiveness and Progression by Inhibiting the Epithelial-Mesenchymal Transition and Stemness in Monotherapy and in Combination Therapy With Temozolomide.

Journal: Phytotherapy research : PTR

Published: August 23, 2023

KITENIN promotes aerobic glycolysis through PKM2 induction by upregulating the c-Myc/hnRNPs axis in colorectal cancer.

KITENIN promotes aerobic glycolysis through PKM2 induction by upregulating the c-Myc/hnRNPs axis in colorectal cancer.

Journal: Cell & bioscience

Published: March 02, 2023

MicroRNA-122 targets δ-catenin to suppress the tumorigenic potential of prostate cancer cells.

MicroRNA-122 targets δ-catenin to suppress the tumorigenic potential of prostate cancer cells.

Journal: American journal of cancer research

Published: September 15, 2022

A peptide interfering with the dimerization of oncogenic KITENIN protein and its stability suppresses colorectal tumour progression.

A peptide interfering with the dimerization of oncogenic KITENIN protein and its stability suppresses colorectal tumour progression.

Journal: Clinical and translational medicine

Published: December 09, 2021

Author Correction: The lichen secondary metabolite atranorin suppresses lung cancer cell motility and tumorigenesis.

Author Correction: The lichen secondary metabolite atranorin suppresses lung cancer cell motility and tumorigenesis.

Journal: Scientific reports

Published: June 18, 2021

Bifunctional Role of CrkL during Bone Remodeling.

Bifunctional Role of CrkL during Bone Remodeling.

Journal: International journal of molecular sciences

Published: May 27, 2021

Showing 1-12 of 66

Last Updated: 09/26/2026